Navion Update: Pfizer Announces Most Favored Nation (MFN) Drug Pricing in the U.S.
On September 30, 2025, during a joint White House press conference, Pfizer announced a landmark pricing agreement to lower drug […]
Q3 2025 FDA Drug Approvals: Wegovy, HIV PrEP, RSV Protection & More
By Beckie Fenrick, PharmD, MBA and Jason Peterson, RPh The FDA’s Q3 2025 approvals mark a pivotal quarter, with new
Pharmacy Spend: Why Clinical Strategy Is the New Cost Strategy
By: Kevin Kobielski, President of Navion For years, the pharmacy benefits conversation has revolved around unit costs, rebates, and discounts.
Navion Launches Pharmacy Partner Portal to Empower Clients with Marketing, Education, and Growth Solutions
Collinsville, CT — Navion, a leader in pharmacy benefit strategy, today announced the launch of its Partner Sales & Marketing
Why Regular Market Checks Are One of the Smartest Moves in Pharmacy Oversight
By: Kevin Kobielski, President of Navion Pharmacy contracts don’t age gracefully. What may have been a strong deal years ago
The Current State of ADHD Medications: Shortages, Safety Risks, and Solutions for Plan Sponsors
By Jason Peterson, RPh; Beckie Fenrick, PharmD, MBA; and Emily Crisano, PharmD, RPh August brings the familiar back-to-school rush—a stressful
For the Third Time, Navion Makes the Inc. 5000 List of the Fastest-Growing Private Companies in America
NEW YORK, August 13, 2025 – Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping
